The outcomes of shoulder arthroplasty in those aged ≥70 years with glenohumeral arthritis: a New Zealand Joint Registry study

About this item

Title

The outcomes of shoulder arthroplasty in those aged ≥70 years with glenohumeral arthritis: a New Zealand Joint Registry study

Content partner

University of Otago

Collection

Otago University Research Archive

Description

Reverse total shoulder arthroplasty (RTSA) was traditionally reserved for the patient with rotator cuff tear arthropathy. As the indications for RTSA continue to expand, the role of RTSA in patients aged >70 years with glenohumeral arthritis and an intact rotator cuff remains unclear. To study the New Zealand Joint Registry (NZJR) and compare the outcomes of a primary Total Shoulder Arthroplasty (TSA), a primary RSA and an RSA performed for revision of a failed TSA in patients aged >70 years,...

Read more

Format

Research paper

Research format

Scholarly text / Journal article

Thesis level

Article

Date created

2022-04

Creator

Mowbray, Jessica / Van Niekerk, Michael / Frampton, Christopher / Hirner, Marc

URL

https://hdl.handle.net/10523/20772

Related subjects

70 years / arthroplasty / Glenohumeral arthritis / outcomes / reverse / total shoulder

What is the copyright status of this item?

All Rights Reserved

This item is all rights reserved, which means you'll have to get permission from University of Otago before using it.

What can I do with this item?

You must always check with University of Otago to confirm the specific terms of use, but this is our understanding:

Non-infringing use

NZ Copyright law does not prevent every use of a copyright work. You should consider what you can and cannot do with a copyright work.

No sharing

You may not copy and/or share this item with others without further permission. This includes posting it on your blog, using it in a presentation, or any other public use.

No modifying

You are not allowed to adapt or remix this item into any other works.

No commercial use

You may not use this item commercially.